Ackerman Capital Advisors, LLC Pfizer Inc Transaction History

Ackerman Capital Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 01, 2021	SELL	$33.47 - $42.56 $255,811 - $325,286	-7,643 Closed	0 $0
Q1 2020 Aug 14, 2020	BUY	$27.03 - $38.62 $206,590 - $295,172	7,643 New	7,643 $249,000
Q3 2019 Oct 09, 2019	SELL	$32.49 - $42.13 $259,920 - $337,040	-8,000 Closed	0 $0
Q2 2019 Jul 23, 2019	BUY	$36.98 - $41.52 $110,939 - $124,560	3,000 Added 60.0%	8,000 $347 Million
Q1 2019 Apr 26, 2019	BUY	$37.5 - $41.2 $187,500 - $206,000	5,000 New	5,000 $212 Million

3,366

3.57B

106M

123M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $126B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Ackerman Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ackerman Capital Advisors, LLC with notifications on news.